We are live on ! Find out more
MFFIA

McIntyre, Freedman & Flynn Investment Advisers Portfolio holdings

AUM $167M
1-Year Est. Return 76.16%
This Fund
S&P 500
This Quarter Est. Return
+2.89%
1 Year Est. Return
+76.16%
3 Year Est. Return
+136.05%
5 Year Est. Return
10 Year Est. Return
AUM
$117M
AUM Growth
-$768K
Cap. Flow
-$3.1M
Cap. Flow %
-2.65%
Top 10 Hldgs %
42.54%
Holding
64
New
2
Increased
11
Reduced
18
Closed
3

Top Buys

Rank Stock Value
1
NEM icon
Newmont
NEM
+$875K
2
BTU icon
Peabody Energy
BTU
+$186K
3
AAPL icon
Apple
AAPL
+$181K
4
OVV icon
Ovintiv
OVV
+$123K
5
RITM icon
Rithm Capital
RITM
+$83.6K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$1.4M
2
HLN icon
Haleon
HLN
+$451K
3
BX icon
Blackstone
BX
+$268K
4
MRO
Marathon Oil Corporation
MRO
+$235K
5
CTVA icon
Corteva
CTVA
+$233K

Sector Composition

Rank Sector Weight
1 Energy 22.8%
2 Technology 20.31%
3 Consumer Staples 11.85%
4 Healthcare 11.38%
5 Materials 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOW icon
26
Dow Inc
DOW
$21.9B
$2.2M 1.88%
41,224
-3,497
-8% -$186K
SU icon
27
Suncor Energy
SU
$74.7B
$1.94M 1.66%
66,125
IBB icon
28
iShares Biotechnology ETF
IBB
$9.85B
$1.84M 1.58%
14,526
V icon
29
Visa
V
$674B
$1.58M 1.35%
6,670
BCE icon
30
BCE
BCE
$21.6B
$1.56M 1.34%
34,300
GLW icon
31
Corning
GLW
$144B
$1.5M 1.28%
42,704
+1
+0% +$33
MTB icon
32
M&T Bank
MTB
$36.8B
$1.4M 1.19%
11,279
OXY icon
33
Occidental Petroleum
OXY
$57.6B
$1.32M 1.13%
22,500
VHT icon
34
Vanguard Health Care ETF
VHT
$19.1B
$1.22M 1.04%
4,980
-25
-0.5% -$6.08K
OVV icon
35
Ovintiv
OVV
$17.1B
$1.21M 1.03%
31,800
+3,400
+12% +$123K
BUD icon
36
AB InBev
BUD
$158B
$1.1M 0.94%
19,325
VDC icon
37
Vanguard Consumer Staples ETF
VDC
$8.03B
$1.09M 0.93%
5,583
SWN
38
DELISTED
Southwestern Energy Company
SWN
$919K 0.79%
152,900
-22,000
-13% -$113K
VIS icon
39
Vanguard Industrials ETF
VIS
$8.48B
$884K 0.76%
4,300
TXN icon
40
Texas Instruments
TXN
$254B
$792K 0.68%
4,400
BTU icon
41
Peabody Energy
BTU
$3.02B
$780K 0.67%
36,000
+8,400
+30% +$186K
AR icon
42
Antero Resources
AR
$11.4B
$767K 0.66%
33,300
EQT icon
43
EQT Corp
EQT
$33.6B
$712K 0.61%
17,300
EPSN icon
44
Epsilon Energy
EPSN
$169M
$568K 0.49%
106,400
BMY icon
45
Bristol-Myers Squibb
BMY
$132B
$451K 0.39%
7,051
+900
+15% +$60.4K
XOM icon
46
ExxonMobil
XOM
$651B
$347K 0.3%
3,239
BIIB icon
47
Biogen
BIIB
$31.1B
$328K 0.28%
1,151
MPTI icon
48
M-tron Industries
MPTI
$355M
$319K 0.27%
28,750
ENLC
49
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$313K 0.27%
29,500
+2,000
+7% +$19.9K
PSX icon
50
Phillips 66
PSX
$89.4B
$285K 0.24%
2,991

Similar funds

McIntyre, Freedman & Flynn Investment Advisers's Q2 2023 Portfolio in Review

As of Q2 2023, McIntyre, Freedman & Flynn Investment Advisers held 64 positions worth $117M, down 0.65% from $118M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

McIntyre, Freedman & Flynn Investment Advisers's Q2 2023 filing shows 2 new, 11 increased, 18 reduced and 3 closed positions. Its largest new stake was Apple: 1,040 shares worth $202K. The largest sale was GSK, an estimated $1.4M.

By sector, the portfolio is most concentrated in Energy at 23% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Staples.

  • McIntyre, Freedman & Flynn Investment Advisers's largest Q2 2023 buy was Apple: 1,040 shares worth $202K.
  • McIntyre, Freedman & Flynn Investment Advisers added most to Newmont in Q2 2023, an estimated $875K increase.
  • McIntyre, Freedman & Flynn Investment Advisers's biggest Q2 2023 reduction was Blackstone, cutting an estimated $268K.
  • McIntyre, Freedman & Flynn Investment Advisers fully exited GSK in Q2 2023, selling an estimated $1.4M.
  • McIntyre, Freedman & Flynn Investment Advisers's ten largest holdings make up 43% of its $117M portfolio in Q2 2023.
  • McIntyre, Freedman & Flynn Investment Advisers opened 2 new positions and closed 3 in Q2 2023.
  • McIntyre, Freedman & Flynn Investment Advisers's portfolio value fell 0.65% quarter-over-quarter to $117M.

Based on McIntyre, Freedman & Flynn Investment Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.